In the first four months of 2026, three brain-computer interface companies earned FDA Breakthrough Device Designation, a ...
Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...
Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE)--Synchron, a brain computer interface company, today announced a Twitter takeover by Philip O’Keefe, one of the patients implanted with the Stentrode ...
The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad, allowing them to control the device entirely by thought using ...
Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...